BioFinance is one of the Canadian Life Science industry's leading investor conferences. The meeting brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology, medical devices, diagnostics and research tools.

On Wednesday, April 25 at 2 p.m. C4 will sponsor a technology transfer track at BioFinance. During two hours of short presentations, C4 members will highlight new technologies available for licensing from Ontario universities and research institutions.

2 p.m. – 3p.m. Innovative Diagnostic Tests and Tools

• Histopathological freezing technologies (CryoCaddy) Lawson Health Research Institute
• Antibody based diagnostic for amyotrophic lateral sclerosis (ALS/Lou Gehrig’s Disease) Robarts Research Institute
• New bacteriophage-based biosensor capable of concentration and detection of specific pathogens in one step. University of Guelph
• Non-invasive test for treatment decisions for cancer patients McMaster University

3 p.m. - 3:30 p.m. New Drug Delivery Systems

• Pulmonary drug delivery system University of Western Ontario
• New functional foods for the treatment of allergy.  A mint tea high in rosmarinic acid, a compound shown to be an effective treatment of hayfever. University of Guelph
• Novel biomaterials for ophthalmic applications McMaster University

3:30 p.m. – 4 p.m. Medical Regeneration

• An in vitro approach to the treatment of osteoporosis and fractures. McMaster University
• Therapeutic method of altering scar following disease and/or injury suitable for treating spinal cord injuries. Robarts Research Institute